Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Buy
203,872
+24,057
+13% +$75.2K 0.01% 409
2026
Q1
$525K Sell
179,815
-5,993
-3% -$17.1K 0.01% 467
2025
Q4
$459K Sell
185,808
-11,126
-6% -$26.5K 0.01% 513
2025
Q3
$439K Buy
196,934
+25,310
+15% +$57.9K ﹤0.01% 533
2025
Q2
$414K Buy
171,624
+26,793
+18% +$65.2K ﹤0.01% 519
2025
Q1
$337K Buy
144,831
+32,131
+29% +$64.3K ﹤0.01% 527
2024
Q4
$208K Sell
112,700
-18,547
-14% -$41K ﹤0.01% 638
2024
Q3
$269K Buy
131,247
+16,643
+15% +$37.3K ﹤0.01% 726
2024
Q2
$284K Buy
114,604
+26,821
+31% +$61.1K ﹤0.01% 577
2024
Q1
$218K Buy
87,783
+6,064
+7% +$15.8K ﹤0.01% 472
2023
Q4
$211K Buy
81,719
+17,715
+28% +$47.9K ﹤0.01% 434
2023
Q3
$204K Buy
64,004
+46,191
+259% +$134K ﹤0.01% 429
2023
Q2
$50K Sell
17,813
-90,963
-84% -$268K ﹤0.01% 691
2023
Q1
$296K Buy
108,776
+40,001
+58% +$105K ﹤0.01% 410
2022
Q4
$194K Buy
68,775
+34,962
+103% +$102K ﹤0.01% 462
2022
Q3
$85K Buy
33,813
+32,902
+3,612% +$93.3K ﹤0.01% 581
2022
Q2
$3K Buy
+911
New +$2.6K ﹤0.01% 1540

Other funds holding ABEV

Blue Trust Inc's ABEV Position: Q2 2026 in Review

Blue Trust Inc increased its Ambev (ABEV) stake by 13% in Q2 2026, buying an estimated $75.2K and bringing the position to 203,872 shares worth $640K. The position accounts for 0.01% of the portfolio, ranked #409.

Blue Trust Inc first reported a position in ABEV in Q2 2022 and has held it in 17 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Blue Trust Inc held 203,872 shares of Ambev worth $640K as of Q2 2026.
  • Blue Trust Inc bought 24,057 Ambev shares in Q2 2026, an estimated $75.2K.
  • Ambev made up 0.01% of Blue Trust Inc's portfolio in Q2 2026, its #409 holding.
  • Blue Trust Inc first reported a position in Ambev in Q2 2022 and has held it in 17 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.